Almirall, S.A. announced that Karin Louise Dorrepaal has been appointed, by co-option, independent board member of the company, whose Board of Directors comprises ten members. The appointment will take effect as of January 1, 2013 and will be ratified in Almirall's next Annual General Meeting. Dorrepaal, from Holland, has a PH.D. in Medicine as well as a MBA together with an extensive professional career spanning over 25 years during which she has held top level positions in the pharmaceutical sector and the international strategic consultancy area.

Karin Louise Dorrepaal has led various pharmaceutical business model transformation processes and currently holds non-executive positions in companies related to the healthcare sector and consultancy. Her experience, her business acumen and her global insight validate her appointment.